Dihydroartemisinin Reduces Irradiation-Induced Mitophagy and Radioresistance in Lung Cancer A549 Cells via CIRBP Inhibition

• Published in: Life (Basel, Switzerland) Vol. 12; no. 8; p. 1129
• Main Authors: Wu, Shunlong, Li, Zhaodong, Li, Haiyu, Liao, Kui
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 27.07.2022; MDPI
• Subjects: Antibodies; Artemisinin; Autophagy; Binding sites; Bioinformatics; Cancer therapies; Cell cycle; Dihydroartemisinin; Drug dosages; Flow cytometry; fractional radiation; Gene expression; Homeostasis; Irradiation; Kinases; Lung cancer; Metastasis; Mitochondria; Mitophagy; Molecular modelling; Proteins; Proteomics; PTEN-induced putative kinase; Radiation; Radiation effects; Radiation therapy; Radiation tolerance; Radioresistance; radiotherapy; RNA-binding protein; United States > US; China
• ISSN: 2075-1729; 2075-1729
• DOI: 10.3390/life12081129

Radiotherapy is a major therapeutic strategy for lung cancer, and radiation resistance (radioresistance) is an important cause of residual and recurring cancer after treatment. However, the mechanism of radioresistance remains unclear. Mitochondrial autophagy (mitophagy), an important selective autophagy, plays an important role in maintaining cell homeostasis and affects the response to therapy. Recent studies have shown that dihydroartemisinin (DHA), a derivative of artemisinin, can increase the sensitivity to treatment in multiple types of cancer, including lung cancer. The purpose of this study was to elucidate the function and molecular mechanisms of DHA-regulating mitophagy and DHA-reducing radioresistance in lung cancer A549 cells. We first constructed the radioresistant lung cancer A549 cells model (A549R) through fractional radiation, then elucidated the function and mechanism of DHA-regulating mitophagy to reduce the radioresistance of lung cancer by genomic, proteomic, and bioinformatic methods. The results showed that fractional radiation can significantly induce radioresistance and mitophagy in A549 cells, DHA can reduce mitophagy and radioresistance, and the inhibition of mitophagy can reduce radioresistance. Protein chip assay and bioinformatics analysis showed the following: Cold-Inducible RNA Binding Protein (CIRBP) might be a potential target of DHA-regulating mitophagy; CIRBP is highly expressed in A549R cells; the knockdown of CIRBP increases the effect of DHA, reduces mitophagy and radioresistance, and inhibits the mitophagy-related PINK1/Parkin pathway. In conclusion, we believe that DHA reduces radiation-induced mitophagy and radioresistance of lung cancer A549 cells via CIRBP inhibition.